AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal

(RTTNews) - British drug major AstraZeneca Plc (AZN, AZN.L) announced Monday that it has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company, for a total consideration of up to $1 billion, on a cash and debt free basis. https://www.nasdaq.com/articles/astrazeneca-buy-belgiums-cell-therapy-firm-esobiotec-1-bln-deal